Andrew Carollo Md is categorized under Orthopedic Doctors and Physicians in Elizabeth, NJ and active since 1962.
Andrew Carollo Md was established in 1962, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Andrew Carollo at the company’s single location by writing to 701 Newark Avenue # 101, Elizabeth, New Jersey NJ 07208 or by phoning (908) 355-7447. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Andrew Carollo Md |
| Contact Person: | Andrew Carollo |
| Address: | 701 Newark Avenue # 101, Elizabeth, New Jersey 07208 |
| Phone Number: | (908) 355-7447 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1962 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Andrew Carollo Md was started in 1962 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Andrew Carollo for inquiries that concern Andrew Carollo Md by calling the company number (908) 355-7447, as your correspondence is most welcome. Additionally, the physical location of the single location of Andrew Carollo Md can be found at the coordinates 40.679982,-74.209404 as well as the street address 701 Newark Avenue # 101 in Elizabeth, New Jersey 07208.
For its online presence, you may visit Andrew Carollo Md’s website at and engage with its social media outlets through on Twitter and on Facebook.